XML 93 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS' EQUITY - Share Based Comp (Details) - $ / shares
12 Months Ended
Mar. 15, 2023
Mar. 17, 2022
Mar. 04, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restricted Stock Awards            
Restricted Stock Awards            
Nonvested at the beginning of the period (in shares)       1,849,796    
Granted (in shares)       687,893    
Vested (in shares)       (976,154)    
Canceled or expired (in shares)       53,779    
Nonvested at the end of the period (in shares)       1,615,314 1,849,796  
Weighted Average Grant Date Fair Value            
Nonvested at the beginning of the period (in dollars per shares)       $ 37.36    
Granted (in dollars per shares)       57.53 $ 40.16 $ 44.26
Vested (in dollars per shares)       31.71    
Cancelled or expired (in dollars per shares)       43.34    
Nonvested at the end of the period (in dollars per shares)       $ 51.61 $ 37.36  
Grant Date, March 15, 2023 | Market Condition Award            
Assumptions used in valuation            
Dividend yields (as a percent) 1.21%          
Expected volatility (as a percent) 46.54%          
Risk-free interest rate (as a percent) 3.81%          
Expected life (in years) 3 years          
Weighted Average Grant Date Fair Value            
Granted (in dollars per shares) $ 63.33          
Grant Date, March 17, 2022 | Market Condition Award            
Assumptions used in valuation            
Dividend yields (as a percent)   1.31%        
Expected volatility (as a percent)   54.25%        
Risk-free interest rate (as a percent)   2.09%        
Expected life (in years)   3 years        
Weighted Average Grant Date Fair Value            
Granted (in dollars per shares)   $ 44.25        
Grant Date, March 4, 2021 | Market Condition Award            
Assumptions used in valuation            
Dividend yields (as a percent)     1.12%      
Expected volatility (as a percent)     53.03%      
Risk-free interest rate (as a percent)     0.29%      
Expected life (in years)     3 years      
Weighted Average Grant Date Fair Value            
Granted (in dollars per shares)     $ 54.92